• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

BioGaia

120.50 SEK

-1.23 %

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.23 %
-2.27 %
+3.08 %
+14.76 %
+13.47 %
+14.00 %
+3.88 %
+22.83 %
+1,596.39 %

BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.

Read more
Market cap
12.19B SEK
Turnover
2.53M SEK
Revenue
1.54B
EBIT %
26.82 %
P/E
36.63
Dividend yield-%
3.32 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
17.7
2026

Interim report Q2'26

22.10
2026

Interim report Q3'26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

BioGaia, Audiocast, Q2'26
Webcast17.07.2026, 09.30

BioGaia, Audiocast, Q2'26

BioGaia
Regulatory press release07.05.2026, 18.00

Bulletin from Annual General Meeting of BioGaia AB (publ)

BioGaia
BioGaia, Audiocast, Q1'26
Webcast07.05.2026, 09.30

BioGaia, Audiocast, Q1'26

BioGaia

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release07.05.2026, 08.00

BioGaia AB: Interim Management Statement January - March 2026

BioGaia
Regulatory press release30.03.2026, 15.00

Notice to attend the Annual General Meeting of BioGaia AB (publ)

BioGaia
Regulatory press release30.03.2026, 11.00

BioGaia Annual and Sustainability Report 2025 published

BioGaia
Press release17.03.2026, 13.00

BioGaia exercises option to acquire remaining shares in Nutraceutics

BioGaia
BioGaia, Audiocast, Q4'25
Webcast12.02.2026, 09.30

BioGaia, Audiocast, Q4'25

BioGaia
Regulatory press release12.02.2026, 08.00

BioGaia AB: Year-end report January - December 2025

BioGaia
Regulatory press release03.02.2026, 08.00

BioGaia's results for the fourth quarter to exceed market expectations

BioGaia
BioGaia, Audiocast, Q3'25
Webcast22.10.2025, 09.30

BioGaia, Audiocast, Q3'25

BioGaia
Regulatory press release22.10.2025, 08.00

BioGaia AB: Interim Management Statement January - September 2025

BioGaia
Regulatory press release22.08.2025, 17.30

Extraordinary General Meeting of BioGaia

BioGaia
Regulatory press release25.07.2025, 09.30

Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)

BioGaia
BioGaia, Audiocast, Q2'25
Webcast18.07.2025, 09.30

BioGaia, Audiocast, Q2'25

BioGaia
Regulatory press release18.07.2025, 08.00

BioGaia AB: Interim Report January - June 2025

BioGaia
Press release16.07.2025, 10.00

BioGaia AB launches a subsidiary company - BioGaia New Sciences AB - dedicated to advancing microbiome research and innovation

BioGaia
Regulatory press release30.05.2025, 11.00

Change in the number of votes in BioGaia AB (publ)

BioGaia
Regulatory press release07.05.2025, 18.30

Annual General Meeting of BioGaia

BioGaia
BioGaia, Audiocast, Q1'25
Webcast07.05.2025, 09.30

BioGaia, Audiocast, Q1'25

BioGaia